Introduction
Both cigarette smoking and environmental tobacco smoke have been assessed in relation to a variety of neurologic disorders [1] [2] [3] [4] [5] [6] [7] [8] . Currently lacking are published reports examining associations between smoking and risk of narcolepsy, a sleep disorder characterized by excessive daytime sleepiness, and cataplexy, an episodic weakness triggered by strong emotions [9] . Results of family and twin studies implicate both genetic and environmental factors in the development of narcolepsy [10] . One etiologic model for the development of narcolepsy proposes that an autoimmune or environmental factor selectively destroys hypocretin-producing cells in the lateral hypothalamus in genetically susceptible individuals, defined as carriers of the HLA DQB1 * 0602 allele [9, 11] . If tobacco smoke is related to narcolepsy, we might expect passive smoking to be more influential than active smoking given that symptoms of narcolepsy usually manifest themselves in adolescence and that exposure in childhood to passive smoke occurs more commonly than to active smoking. We conducted a case-control study to assess the risk of narcolepsy associated with active and passive smoking among genetically susceptible individuals. To avoid selection bias associated with recruiting patients exclusively from referral or specialty clinics and to preserve the population-based nature of our study, we recruited cases and controls from the general community in King County, Wash., USA [12] . We were also interested in the etiology of narcolepsy specifically among genetically susceptible individuals, since they may be particularly sensitive to the effects of environmental precipitating factors yet to be identified. Driven by this theoretical framework, we restricted our population-based casecontrol study to individuals who were positive for HLA DQB1 * 0602.
Patients and Methods

Recruitment
Recruitment methods for cases are described in detail elsewhere [12] . Briefly, we attempted to identify all prevalent cases of physician-diagnosed narcolepsy who were 18 years and older and residing in King County as of July 1, 2001 . A total of 425 cases were entered into the registry. Consent to participate and provide a buccal specimen was requested from each participant. To be considered eligible for the case-control study, we required cases to carry at least one HLA DQB1 * 0602 allele and be within the 18-to 50-year age range. Of the 279 cases interviewed, 138 (49%) were positive for the HLA DQB1 * 0602 allele, and 67 of these were also eligible regarding age for the case-control study.
Residents of King County without narcolepsy and within the 18-to 50-year age range were identified through random-digit dialing and recruited as controls. Potential controls within households were sampled using randomized recruitment methods in which age-and gender-specific sampling fractions were applied to create a distribution of controls similar to that of the projected distribution of cases [13] . Of 1,203 controls eligible to participate, 448 (37%) completed interviews. Ninety-five controls carried at least one HLA DQB1 * 0602 allele and were eligible for the casecontrol study.
Data Collection
Trained professionals administered in-person interviews to cases and controls using a standardized exposure questionnaire. To determine history of active smoking, subjects were asked if they had ever smoked a cigarette, if they had ever smoked at least 100 cigarettes, the year of smoking initiation, duration of smoking, average number of cigarettes smoked per day, number of years smoked before age 21, and use of cigars, pipes and snuff before age 21. Passive smoking before age 21 was determined by assessing if and how long subjects had lived with persons who smoked cigarettes, including parents (father, stepfather, mother, and stepmother), other family members (grandparents and siblings) and other unrelated household members. Subjects were also asked about their exposure to cigarette smoke at work. Information on demographic factors including age, gender, race, income, and education was obtained during the interview. The University of Washington's institutional review board approved the study.
Analysis
Variables were constructed to characterize exposure to active smoking in terms of dichotomous exposure (ever/never), duration of smoking in years, average number of cigarettes per day, and cumulative smoking in pack-years. We also had information on age of smoking initiation, which enabled us to examine whether smoking initiation occurred before age of narcolepsy onset for cases and before a corresponding index date for controls. For passive smoking, we created a summary variable that described the total number of related and unrelated household smokers with whom subjects lived before age 21. Continuous variables were transformed into categorical variables for which the unexposed category served as reference group, and the median value among exposed controls served as the cutoff for the remaining exposed groups. Tests for linear trend were conducted for variables with more than two ordered categories. All p values presented are two sided.
We also restricted our analysis for passive smoking to subjects who did not report any active smoking. We attempted a similar analysis for active smoking whereby we excluded subjects exposed to passive smoking; however, because nearly all active smokers also reported exposure to passive smoking, our analysis suffered from low power, and, in many circumstances, produced statistically unstable estimates. All analyses were repeated restricting to cases with cataplexy. To assess whether age of onset (and the corresponding index date for controls) modifies the association between smoking and narcolepsy, we stratified our analyses by the median age of onset (i.e. younger than 14 years vs. 14 years and older).
Unconditional logistic regression was used to obtain estimated odds ratios (ORs) and 95% confidence intervals (CIs), adapted to account for the sampling mechanism for controls [13] . Because household income was missing for 5 cases and 7 controls, we multiply imputed household income using age, African-American race, interview year and case status as predictors [14] . All regression models were adjusted for African-American race and income. Other variables such as education and caffeine intake were assessed for their confounding effects in multivariate models. Imputation was performed using the mice package in R statistical language, version 2.5 [15] . All other analyses were conducted in Stata version 9.2 [16] .
Results
Cases and controls did not differ significantly in regard to age and gender. However, cases were slightly more likely to have had a graduate school education than controls, were significantly more likely to be African-American, and significantly less likely to have higher levels of household income ( table 1 ) .
Results for active smoking are summarized in table 2 . We did not observe any significant association between narcolepsy and active smoking exposures. Adjustment for coffee consumption before age 21 and education did not appreciably change estimates (data not shown) and were not included in the final models.
In contrast to active smoking, we observed several significant associations between risk of narcolepsy and passive smoking ( table 3 ) . Although risk of narcolepsy was not associated with parental smoking, it was three-to fourfold higher if other family members or non-family members were smokers. Among those who had at least two smokers in the household, we observed a fivefold increase in narcolepsy risk compared to those who did not live with any smokers. Compared to those who had never lived with a household smoker, risk of narcolepsy was significantly elevated threefold for those who lived with an unrelated household smoker for 1-2 years. Exposure to tobacco smoke at work was not significantly associated with narcolepsy risk.
A subgroup analysis in which passive smoking was assessed among never smokers of 100 cigarettes resulted in even stronger measures of association than in the original unrestricted analysis, some of which remained statistically significant: having lived with a non-family smoking household member was associated with an almost ninefold increased risk of narcolepsy and having lived with an unrelated smoker for 6 3 years increased the risk of narcolepsy by more than eightfold ( table 3 ) .
When we reanalyzed our data by further restricting cases to those with cataplexy (data not shown), associations were essentially unchanged for active smoking. For certain aspects of passive smoking that were already statistically significant in the original analysis, measures of association remained significant. For instance after restricting cases to those with cataplexy, risk of narcolepsy associated with having lived with a related household smoker member other than a parent increased slightly to 3.2 (95% CI: 1.1, 8.3), and the association with having lived with an unrelated smoker increased to 4.4 (95% CI: 1.6, 8.67). We observed no effect modification of the association between passive smoking and narcolepsy when we stratified our analyses according to the median age of onset. The risk of narcolepsy associated with having lived with one household smoker was not different for those whose age at onset was ! 14 years (OR = 0.9; 95% CI: 0.2, 3.2) and those 6 14 years (OR = 1.3; 95% CI: 0.4, 4.3). Likewise, the risk of narcolepsy related to having lived with two or more 
Discussion
Among genetically susceptible individuals, we found no association between narcolepsy and active smoking. On the other hand, we observed significant associations between narcolepsy and passive smoking before age 21, i.e. having lived with related and unrelated household members who smoked. Exposure to tobacco smoke in the workplace was not significantly associated with narcolepsy risk.
Several limitations relating to the general design of our study are notable. First, because we were interested in the etiology of narcolepsy specifically among genetically susceptible individuals, and because sleep studies would not be feasible to incorporate in the recruitment strategy for a population-based study, we only required that cases within the specified age range have a physician diagnosis of narcolepsy and be positive for HLA DQB1 * 0602. In the pursuit of our hypothesis and to preserve the populationbased nature of our study, we may have sacrificed some diagnostic precision typically afforded by sleep studies. We did, however, attempt to address disease misclassification by repeating our analyses restricted to cases with HLA DQB1 * 0602 who also had cataplexy. Second, because our study was small, we were unable to detect more subtle associations that may provide a greater understanding about the etiology of narcolepsy. Third, although we attempted to identify all cases of narcolepsy in King County using multiple methods [12] , we may not have been able to capture all existing cases in the community. Specific to these analyses are a number of other limitations that may have influenced our results. First, although the overall response rate of 37% among controls is typical of that documented in recent studies using similar randomized digit-dialing techniques [17] , this low response rate represents a substantial potential for selection bias when examining smoking history as the primary exposure because, in general, non-respondents are more likely than respondents to be current smokers [18] . If a similar association between passive smoking and participation exists among controls, selection bias may account for part or all of the observed significant associations between passive smoking and narcolepsy. Second, because we relied on questionnaires to examine past exposures of active and passive smoking, our results are vulnerable to differential recall bias, whereby cases would be more likely to recall and report having lived with a smoker than controls. In this particular study where a popular hypothesis linking passive smoking and narcolepsy was lacking, differential recall of passive smoking between cases and controls may be less problematic than in other studies, for example of lung cancer, where passive smoking is highly suspected to be an important risk factor [19] .
Non-differential exposure misclassification is another potential source of error. Because we had no information on precisely when exposure to passive smoke may have occurred in relation to age of narcolepsy onset, our ascertainment of passive smoking before age 21 is likely to include exposure during an etiologically irrelevant time window. Exposure misclassification may also stem from imprecise measurement of passive smoke exposure, which was based on the number of household members who smoked. Ultimately, exposure to passive smoking also depends on other variables such as number of cigarettes smoked in a particular location, size of the room, the ventilation system of the building [20] , none of which was known in this study but might be worth investigating in future studies. An attenuation of estimates resulting from these sources of non-differential misclassification, however, would make the argument for passive smoking even more compelling.
Finally, although we attempted to control for confounding, our results may still be distorted by unmeasured or residual confounding. Studies from the US and United Kingdom suggest that adults exposed to secondhand smoke generally have less healthy lifestyles [21, 22] or that secondhand smoke exposure is associated with correlates of lifestyle that influence health outcomes [23] .
One possible explanation for the positive finding for passive smoking and null results for active smoking could relate to the nature of the disease itself. Narcolepsy typically starts during adolescence [11] . Cases in this study had a median age at onset of 14 years. A national survey reported only 8.4% of middle-school students and 6.7% of high-school students reported smoking their first cigarette before the age of 11 [24] . In contrast, a far higher proportion of infants, children and youth are potentially exposed to secondhand smoke than to cigarette smoke from active use. In phases I and II of the NHANES III (1988) (1989) (1990) (1991) (1992) (1993) (1994) , 84.7% of children aged 4-11 years had a serum cotinine level indicative of nicotine metabolism presumably from exposure to passive smoke [25, 26] . In contrast to active cigarette smoking, exposure to passive smoking may be considered more etiologically relevant to narcolepsy due to the timing of exposure in relation to disease onset. The explanation for the lack of association for exposure to secondhand smoke in the workplace may follow a similar argument in which employment before age 21 precludes ages defined by infancy and childhood when cigarette smoking has not been initiated, but when exposure to passive smoking can be highly prevalent.
Whether different etiologies exist for those who develop narcolepsy earlier than for those in whom disease onset occurs later remains speculative. Evidence of a modifying effect of age at onset on the association between passive smoking and narcolepsy could suggest disparate etiologies for those who develop the disease at a younger age than those in whom onset occurs much later. However, we did not observe any such effect modification in our data.
Curiously, while associations related to certain passive smoking exposures were strong, we observed a lack of association between narcolepsy risk and having at least one parent who smoked while subjects were 21 years or younger. If a biological mechanism exists to explain the observed association between passive smoking and narcolepsy, this null finding may be due to increased awareness among smoking parents of the adverse health effects of secondhand smoke in the home [27] , or to implementations of in-home smoking bans among smoking parents [28] , or possibly to an underlying distribution of socioeconomic factors from residual confounding. Alterna-tively, although the observed associations represent intriguing possibilities in the etiology of narcolepsy, our findings could simply be due to chance.
Possibly, passive smoking represents an environmental insult occurring during an etiologically relevant time period and initiating the destruction of hypocretin-producing cells in genetically susceptible individuals. In contrast to active smoking, exposure to environmental tobacco smoke is likely to occur during critical periods of brain development that precede the potential onset of narcolepsy. Environmental tobacco smoke contains over 4,000 chemical components as well as contaminants such as pesticides, many of which are implicated in neuronal cell death and in the underlying pathology of neurodegenerative diseases. Environmental tobacco smoke is also associated with serious bacterial infections [29] . Neurologic disorders with a hypothesized autoimmune etiology have been known to result from streptococcal infections [30] . In the case of narcolepsy, exposure to passive smoke may increase the likelihood of streptococcal infections due to immunosuppression [31] [32] [33] , which in turn could trigger an autoimmune response leading to the selective destruction of hypocretins in the lateral hypothalamus of people with HLA DQB1 * 0602.
Few population-based studies have been conducted in the field of narcolepsy because of the many challenges that exist for studying such a disease [11, 12] . Despite numerous limitations, our efforts represent an attempt to incorporate HLA typing into a population-based study designed to explore etiologic factors implicated in the gene-environment hypothesis. Given that nicotine and other tobacco smoke constituents are potent neurotoxicants, our results represent preliminary suggestions of a possible role for passive smoking in the development of narcolepsy among genetically susceptible individuals. Replication of these findings is needed.
